NewAmsterdam Pharma Company NV will host an R&D Day event on June 11, 2025, in New York City. The late-stage clinical biopharmaceutical company will present its developments in oral, non-statin medicines for patients at risk of cardiovascular disease with elevated LDL-C. The event will feature members of the management team, and a live webcast will be available for virtual attendees.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.